VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1508380
Sex: F
Age:
State: CA

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Injection site pain; Fever; Sore muscles; Sore body; Nausea; Hot flashes; Swelling of tonsils; Throat pain; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 02Apr2021 at 15:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any medications within two weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 19:45, 4 hours after the vaccination, the patient experienced injection site pain, fever, sore muscles/body, nausea, hot flashes and swelling of tonsils/throat pain. The adverse events neither resulted in doctor or other healthcare professional office/clinic visit nor emergency room/department or urgent care. The patient did not receive treatment for the reported adverse events. The clinical outcome of the events injection site pain, fever, sore muscles/body, nausea, hot flashes and swelling of tonsils/throat pain was resolved on unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508381
Sex: F
Age:
State: OK

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Headache; Sore arm; Feeling of heaviness in body; Severe hot flashes; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 03Apr2021 at 10:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to adhesive. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 12:00, the patient experienced headache, sore arm, feeling of heaviness in body and severe hot flashes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events headache, sore arm, feeling of heaviness in body and severe hot flashes was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508382
Sex: M
Age:
State: NJ

Vax Date: 04/04/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Shooting lights in left eye; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8727) via an unspecified route of administration in the left arm on 04Apr2021 at 15:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have allergies to medications, food, or other products. The patient received unspecified concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 05Apr2021, on the second day, the patient experienced shooting lights in the left eye. The patient reported that he had no issues on the day of the shot. The events did not result in a doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient did not receive any treatment for the event. The clinical outcome of the event shooting lights in left eye was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508383
Sex: F
Age:
State:

Vax Date: 03/31/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Period came 1 week early.; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration on 31Mar2021 at 11:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and precancerous breast lump removal. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), ibuprofen (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration on 10Mar2021 at 08:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 the patient experienced period came 1 week early. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of irregular menstruation was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: EFFEXOR; IBUPROFEN

Current Illness:

ID: 1508384
Sex: F
Age:
State:

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Injection site pain; Tiredness; Felt fuzzy; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05Apr2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05Apr2021, the patient experienced injection site pain, tiredness and felt fuzzy. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events injection site pain, tiredness and felt fuzzy were unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508385
Sex: F
Age:
State: NY

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Swollen lymph nodes; Swollen tongue at time of administration; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the right arm on 01Apr2021 at 15:00 (at the age of 55-years-old) as a single dose for COVID-19 immunization. Medical history included allergy, asthma and bipolar. Concomitant medications included lamotrigine (LAMICTAL), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), clonazepam (KLONOPIN) and primidone (MANUFACTURER UNKNOWN) on an unknown dates for unknown indication. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 12Mar2021 at 14:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 01Apr2021, the patient experienced swollen tongue at the time of administration. On 03Apr2021 at 16:00 two days after vaccination, the patient experienced swollen lymph nodes. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office or clinic and emergency room or department or urgent care. The clinical outcome of the events swollen tongue and swollen lymph nodes were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LAMICTAL; ADDERALL; KLONOPIN; PRIMIDONE

Current Illness:

ID: 1508386
Sex: M
Age:
State: MO

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Watery diarrhea; Fatigue; Malaise; Nausea; Vomiting; Arm soreness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 03Apr2021 at 08:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on 21Dec2020, hypertension (HTN) and hyperlipidemia. The patient did not have allergies to medications, food, or other products. Concomitant medications were not reported. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination On 04Apr2021 at 08:00, the patient experienced watery diarrhea, fatigue, malaise, nausea, vomiting, arm soreness and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient did not receive any treatment for the events. The clinical outcome of the events watery diarrhea, fatigue, malaise, nausea, vomiting, arm soreness and headache was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508387
Sex: F
Age:
State: NJ

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Nauseous; Night sweats; Chills / more of the chills; Headache; Aching all over; Off balance/ head felt like it was swimming off balance; Throwing up; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 30Mar2021 at 15:30 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications included simvastatin (MANUFACTURER UNKNOWN), buspirone (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and fluoxetine (MANUFACTURER UNKNOWN) all for unknown indications from an unknown dates. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 15:00, the patient started experiencing chills and headache. By the night, the patient experienced aching all over, throwing up and off balance. On 01Apr2021, the patient experienced more of the chills, nauseous and head felt like it was swimming off balance. On an unknown date in Apr2021, the patient experienced night sweats. The patient experienced headache the whole time. The patient did not receive any treatment for the events. The clinical outcome of the events chills, headache, loss of balance, night sweats and nauseous was resolved on an unknown date in Apr2021.The clinical outcome of the events general body pain and vomiting resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SIMVASTATIN; BUSPIRONE; BUPROPION; FLUOXETINE

Current Illness:

ID: 1508388
Sex: F
Age:
State: GA

Vax Date: 03/29/2021
Onset Date: 03/30/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Diarrhea; Abdominal cramping; This is a spontaneous report from a contactable physician. A 23-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on 29Mar2021 (at the age of 23-year-old) at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took clindamycin for wisdom tooth extraction 2 weeks prior to vaccine. On 30Mar2021, the patient experienced abdominal cramping first 24 hours after vaccination, resolved, then abdominal cramping with diarrhea started 5 days after vaccination (03Apr2021) and persisted for 3 days until today when seen in office and report made. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of abdominal cramp and diarrhea included oral hydration. The outcome of abdominal cramping occurred on 30Mar2021 was recovered in 2021, then it re-occurred on 03Apr2021 and not recovered; diarrhea was not recovered. This report was reported as non-serious by reporter. Information about lot/batch number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1508389
Sex: F
Age:
State: NJ

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Metal taste in throat and mouth; Heart rate up and racing; Blood pressure went up; Became hot; Nose tingling; Itchy nose; Numb nose; Chest tighten; Tired; Sore legs; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8729) via an unspecified route of administration in the left arm on 05Apr2021 at 09:00 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy NOS. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 09:30 the patient experienced metal taste in throat and mouth, heart rate up and racing, blood pressure went up, became hot, nose tingling, itchy nose, numb nose, chest tighten, tired and sore legs. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported adverse events. On an unknown date, the patient underwent heart rate and blood pressure test and the result was increased. The clinical outcome of the events metal taste in throat and mouth, heart rate up and racing, blood pressure went up, became hot, nose tingling, itchy nose, numb nose, chest tighten, tired and sore legs were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness: Allergy NOS (Allergies to medications, food, or other products: Yes)

ID: 1508390
Sex: F
Age:
State: CA

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Headache; Rapid heartbeat; Hives on face and neck; Rash on neck; Itchiness; Watery eyes; Extreme dryness on face; Sore arm at injection site; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 27Mar2021 at 12:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the arm left on 05Mar2021 at 14:45 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient was not allergic to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 15:30, the patient experienced headache, rapid heartbeat, hives on face and neck, rash on neck, itchiness, watery eyes, extreme dryness on face and sore arm at injection site. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, rapid heartbeat, hives on face and neck, rash on neck, itchiness, watery eyes, extreme dryness on face and sore arm at injection site were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508391
Sex: M
Age:
State: NC

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Feeling dizzy; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8727) via an unspecified route of administration in the left arm on 22Mar2021 at 15:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included pre-diabetic. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Mar2021 at 17:30, the patient experienced feeling dizzy. The patient did not receive any treatment for the event. The patient was feeling dizzy after an hour took a nap and felt better after. The clinical outcome of the event feeling dizzy was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508392
Sex: F
Age:
State:

Vax Date: 03/30/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Period came two days early.; This is a spontaneous report received from a non-contactable consumer, the patient. A 23-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201), via an unspecified route of administration in the left arm on 30Mar2021, as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included TRI SPRINTEC for unknown indication from unknown dates. The patient had not received any other vaccines within 4 weeks prior to COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19.Since the vaccination the patient has been tested for COVID-19. On 05Apr2021, the patient underwent COVID-19 test and the result found to be negative. On 05Apr2021, the patient had irregular menstruation. It was reported that period came two days early despite birth control keeping period on same schedule for last 6 years. The clinical outcome of irregular menstruation was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1508393
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 03/21/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Heavy breathing; Binge eating sugary foods; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on an unknown date at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Patient had no known allergies. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) and birth control (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Mar2021 at 16:00 the patient experienced heavy breathing, binge eating sugary foods within 6 hours after both the first vaccination and second vaccination. Patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 30Mar2021, the patient underwent color (covid test type post vaccination was nasal swab) and the result was negative. The clinical outcome of the events heavy breathing and binge eating sugary foods was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: GABAPENTIN

Current Illness:

ID: 1508394
Sex: F
Age:
State: IL

Vax Date: 03/21/2021
Onset Date: 04/04/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: 1.5 inch round raised welt at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 21Mar2021 at 15:00 (at the age of 16-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included ethinylestradiol; norgestimate (TRI-LO-SPRINTEC) and biotin supplement (MANUFACTURER UNKNOWN); both on unknown dates for unknown indications. The patient had no allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04Apr2021, the patient experienced 1.5 inch round raised welt at the injection site. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the event 1.5 inch round raised welt at the injection site was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TRI-LO-SPRINTEC; BIOTIN

Current Illness:

ID: 1508395
Sex: F
Age:
State: PA

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Left Eye pain; Headache; This is a spontaneous report from a contactable pharmacist. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 03Apr2021 at 11:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus and allergy to sulfa. Concomitant medications included insulin lispro (HUMALOG) for type 1 diabetes mellitus and acetylsalicylic acid (ASPIRIN) 81 mg daily for an unknown indication, both taken from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 13:15, within 2 hours of receiving vaccination, the patient experienced headache. On 03Apr2021 around 19:00, the patient experienced left eye pain which was ongoing. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events headache and left eye pain was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: HUMALOG; Aspirin

Current Illness:

ID: 1508396
Sex: F
Age:
State: PA

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Blood sugars were elevated. Average blood sugar readings are 130 and lower. They were running 200-302 for most of the 4 days following the injection.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 12:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes (controlled) from an unspecified date. Concomitant medications included metformin (MANUFACTURER UNKNOWN), fluoxetine (MANUFACTURER UNKNOWN) all from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 17:00 the patient experienced blood sugars were elevated. Average blood sugar readings were 130 and lower. They were running 200-302 (UNITS UNSPECIFIED) for most of the 4 days following the injection. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event Blood sugar increased was recovered on an unspecified date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: METFORMIN; FLUOXETINE

Current Illness:

ID: 1508397
Sex: F
Age:
State: AZ

Vax Date: 04/04/2021
Onset Date: 04/04/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Brain fog; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 04Apr2021 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021, the patient experienced brain fog. Event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event brain fog was recovering at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508398
Sex: F
Age:
State:

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: itching all over; hives on chest; thickness feeling in throat; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old female patient received the second the dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8783) via an unspecified route of administration in the left arm on 02Apr2021 at 19:45 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not have allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 12Mar2021 at 19:45 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 21:30, within 1.5 hours of second shot, the patient experienced itching all over, hives on chest and thickness feeling in throat. The patient was treated with diphenhydramine (BENADRYL) 50mg for the reported adverse events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events itching all over, hives on chest and thickness feeling in throat was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1508399
Sex: F
Age:
State: TX

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Heart Palpitations; Fatigue; Muscle aches; Headache; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration on 03Mar2021 at 10:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included stomach gastritis reportedly weeks after. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received penicillin and experienced allergy. On 03Mar2021 at 11:30, after 1-2 hours of vaccination, the patient experienced heart palpitations, muscle ache, fatigue and headache. On 03Mar2021 at 11:32, heart palpitations resolved after lasting for 2 minutes. On 04Mar2021, muscle ache, fatigue and headache resolved after lasting for one day. The patient called to report heart palpitations but this was considered normal yet patient felt there was no mention of this as a possible side effect. On 17Mar2021, post vaccination, the patient underwent oral swab test and the result was negative. The adverse events neither resulted in doctor or other healthcare professional office/clinic visit nor emergency room/department or urgent care. It was unknown whether the patient received treatment for the reported adverse events. The clinical outcome of the events heart palpitations resolved on 03Mar2021 at 11:32, muscle ache, fatigue and headache were resolved on 04Mar2021. The patient had not received the second dose at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508400
Sex: F
Age:
State: FL

Vax Date: 03/06/2021
Onset Date: 03/06/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Tingling in my right ring and pinky fingers; Tingling in the right jaw that started near the ear, the front of the mouth, including the tip of the tongue; Numbness in the right jaw started near the ear progressed down my teeth toward the front of my mouth; This is a spontaneous report received from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6201), via an unspecified route of administration in the right arm on 06Mar2021 at 11:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history and known allergies were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6208) via an unspecified route of administration in the left arm on 27Mar2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications within two weeks of vaccination. On 06Mar2021 at 11:00, after about 20 minutes of receiving the first COVID-19 vaccine dose, the patient experienced tingling in her right ring and pinky fingers. Then quickly the patient experienced tingling and numbing in her right jaw that started near the ear and progressed down her teeth toward the front of her mouth including the tip of her tongue. The patient felt like she received a novacaine shot from the dentist. The tingling and numbness continued through out the day into the evening. When the patient retired to sleep, just a bit of numbness on the tongue had remained. Following day the patient experienced additional tingling in that right hand in the ring and pinky fingers. The adverse events did not result in a visit to the doctors or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events tingling in right ring and pinky fingers, tingling in the right jaw that started near the ear, the front of the mouth, including the tip of the tongue, numbness in the right jaw started near the ear progressing down the teeth toward the front of mouth were recovered on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1508401
Sex: F
Age:
State: PA

Vax Date: 04/02/2021
Onset Date: 04/03/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Large raised, reddened area around sight of injection. 2 inches in diameter; Large raised, reddened area around sight of injection; Large raised, reddened area around sight of injection. 2 inches in diameter. Painful.; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 02Apr2021 at 15:45 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19 on unknown dates. The patient did not receive any concomitant medications. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 03Apr2021 at 07:00, the patient experienced large raised, reddened area around site of injection that is 2 inches in diameter, painful and not itchy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events large raised, reddened area around site of injection that is 2 inches in diameter, painful and not itchy was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1508402
Sex: F
Age:
State: NC

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: I am on day 12 of low-grade fever.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 25Mar2021 at 10:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma from an unknown date. Concomitant medications included fluticasone propionate and salmeterol xinafoate (ADVAIR), cetirizine hydrochloride (ZYRTEC) and OTC probiotics from an unknown date for an unknown indication. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) in the left arm on 25Feb2021 at 10:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 13:00 the patient experienced low-grade fever. The highest hit was 100.8 measured with a forehead/temple touch thermometer. Most of the time it would register between 99.7-100.3. The patient generally had a lower than average temperature, something like 98.2. In 2021, the patient was checked for body temperature and the result was 100.8 The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the event low-grade fever was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: ADVAIR; Zyrtec

Current Illness:

ID: 1508403
Sex: F
Age:
State: NY

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Metallic smell in my nose; This is a spontaneous report from a contactable healthcare professional, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 15:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was not allergic to medications, food, or other products. Concomitant medication included drospirenone, ethinylestradiol betadex clathrate (YAZ) from an unknown date and for unspecified indication. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 18:15 2hours after the vaccination the patient experienced metallic smell in her nose. The patient did not receive any treatment for the reported adverse event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event metallic smell in her nose was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: YAZ

Current Illness:

ID: 1508404
Sex: M
Age:
State:

Vax Date: 04/04/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Vertigo; Dizziness; Arm pain; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 04Apr2021 at 13:30 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: UNKNOWN) via an unspecified route of administration on unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021 the patient experienced vertigo, dizziness, arm pain and fatigue. The patient did not receive any treatment for the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events vertigo, dizziness, arm pain and fatigue were unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508405
Sex: F
Age:
State: MA

Vax Date: 04/04/2021
Onset Date: 04/05/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Muscle pain at injection site; Muscle pain at injection site; This is a spontaneous report from a non-contactable physician. A 55-years-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration on 04Apr2021 at 17:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced muscle pain (muscle pain), at injection site (vaccination site pain). No therapeutic measures were taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events muscle pain and vaccination site pain were not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508406
Sex: F
Age:
State: CA

Vax Date: 03/09/2021
Onset Date: 03/01/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Conjunctivitis- pink eye; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199), via an unspecified route of administration in the left arm on 09Mar2021 at 12:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727), via an unspecified route of administration in the left arm on 30Mar2021 at 15:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unspecified date in Mar2021, the patient experienced conjunctivitis- pink eye. The patient reported that this event occurred for both the doses of the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event experienced. The clinical outcome of the event conjunctivitis- pink eye was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508407
Sex: M
Age:
State:

Vax Date: 03/28/2021
Onset Date: 03/29/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: swollen throat; Bad taste in mouth; sore throat; This is a spontaneous report received from a non-contactable consumer, the patient. A 42-year-old male patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on 28Mar2021 at 11:30 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 29Mar2021, the patient experienced throat swelling, sore throat and bad taste in the mouth. The adverse event resulted in emergency room or department or urgent care. The patient was tested for COVID-19 post-vaccination. The patient underwent a SARS-CoV-2 nasal swab test on 04Apr2021, and the result was negative. The patient received pain medicine as the treatment for the adverse events. The clinical outcome of the events throat swelling, sore throat and bad taste in mouth were not recovered at the time of the report. No follow-up attempts are possible; information about the lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508408
Sex: M
Age:
State: WV

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Extreme dizziness; Nausea; Vomiting; Hot flash; Some congestion; Hoarseness; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 14:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, diabetes and penicillin allergy. Concomitant medications were not reported. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN), both on unknown dates and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 01Apr2021 same day after vaccination (also reported as, on evening of second injection - 02Apr2021), the patient experienced extreme dizziness. nausea, vomiting, hot flash, some congestion and hoarseness for the first time. The patient had sudden recurrence daily of dizziness, nausea and sometimes vomiting. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event extreme dizziness. nausea, vomiting, hot flash, some congestion and hoarseness was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508409
Sex: F
Age:
State: PA

Vax Date: 03/15/2021
Onset Date: 03/25/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Developed shingles on back and chest; This is a spontaneous report from a contactable consumer. A 75-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the right arm on 15Mar2021 at 15:45 (at the age of 75-years-old) as single dose for COVID-19 immunisation. Medical history of the patient included diabetes, COPD (chronic obstructive pulmonary disease), stroke, kidney disease and the patient had a history of allergy to cheap gold. The patient received unspecified medications within two weeks prior to the vaccination for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021, the patient developed shingles on back and chest. The patient received treatment for the events with VALTREX. Adverse event resulted emergency room/department or urgent care. The clinical outcome for the event of developed shingles on back and chest was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508410
Sex: F
Age:
State: DC

Vax Date: 03/31/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Havent been able to getout of bed; My head hurts; Terrible sore throat; No appetite; Fatigue; Chills; Muscular pain; Feeling very sick; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm right on 31Mar2021 at 11:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient had no known allergies to medications, food, or other products. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, patient was tested for COVID-19. On 05Apr2021, the patient had nasal swab COVID-19 virus test and the result found to be unknown. The patient received the vaccine on Wednesday 31Mar2021, and started feeling very sick since Friday 02Apr2021. On Monday 05Apr2021, the patient was feeling as sick, it had not gotten any better, and was not been able to get out of bed. The patient's head was hurting, a terrible sore throat, had no appetite, fatigue, chills and muscular pain. Muscular pain was the only symptom that was getting better. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events malaise, bedridden, headache, sore throat, appetite lost, fatigue, chills and muscular pain was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508411
Sex: F
Age:
State: NJ

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Fell dizziness; I couldn't stand up I was throwing up; my breathing was shallow; Throat was dry; Mouth was dry; Shaking uncontrollably; Heart palpitations; This is a spontaneous report from a contactable other healthcare professional, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3302) via an unspecified route of administration in the left arm on 02Apr2021 at 09:15 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, shellfish and penicillin allergy. concomitant medications included unspecified blood pressure medicine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 19:30 in the evening, the patient fell dizziness, she couldn't stand up she was throwing up, her breathing was shallow, her throat was dry, her mouth was dry, she was shaking uncontrollably and had to call EMT also was getting heart palpitations. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events fell dizziness, couldn't stand up she was throwing up (balance difficulty), breathing was shallow, throat was dry, mouth was dry, shaking uncontrollably and heart palpitations were recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508412
Sex: F
Age:
State: NY

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Body aches; Fever; Nausea; Headache; This is a spontaneous report from a contactable consumer, the patient. A 60-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 01Apr2021 at 08:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and mild depression. The patient not had known allergies to medications, food or other products. Concomitant medications included levothyroxine sodium (SYNTHROID) and lexoprin(MANUUFACTURER UNKNOWN), both from an unknown date, for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 11Mar2021 at 08:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 02:00, the patient experienced fever, nausea, headache and body aches. No therapeutic measures were taken as a result of reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, nausea, headache and body aches was recovered on an unspecified date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: SYNTHROID

Current Illness:

ID: 1508413
Sex: M
Age:
State: GA

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Stomach issues/ stomach ailment; frequent bowel movements with very small amout of stools; Very tired; This is a spontaneous report from a contactable consumer, the patient. An unspecified aged male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 02Apr2021 at 13:45 (age at vaccination was unknown) as a single dose for COVID-19 immunisation. Medical history included allergies (hay Fever). The patient had no known allergies to medications, food or other products. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), from an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 19:30, the patient experienced very tired every day since vaccination, 3 days after vaccination (05Apr2021), the patient experienced stomach issues, (frequent bowel movements with very small amount of stools, as though he had a stomach ailment and was recovering from it. The patient felt much better after he ate something). No therapeutic measures were taken as a result of the reported events. The clinical outcomes of stomach issues, very tired and frequent bowel movements with very small amount of stools were recovering. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: AMLODIPINE

Current Illness:

ID: 1508414
Sex: M
Age:
State: OH

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Mild fever; fatigue; This is a spontaneous report from a contactable consumer. A 59-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 18:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not have a history of allergies to medications, food, or other products. Concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 13Mar2021 at 18:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 15:00 the patient experienced mild fever and fatigue after second dose. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events mild fever and fatigue was recovered on an unknown date in 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508415
Sex: F
Age:
State:

Vax Date: 03/31/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Swelling by the Jaw; This is a spontaneous report from a non-contactable healthcare professional. A 31-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER7835), via an unspecified route of administration in the left arm on 31Mar2021 at 16:45 (at the age of 31-years-old), as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any known allergies to medications, food or other products. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN) started on an unknown date for unspecified indication and fish oil capsule (MANUFACTURER UNKNOWN) started on an unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021, the patient experienced swelling by the jaw. No therapeutic measures were taken as a result of the reported event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swelling by the jaw was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMIN D NOS

Current Illness:

ID: 1508416
Sex: M
Age:
State: FL

Vax Date: 03/15/2021
Onset Date: 03/01/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Rash at injection site; Soreness at injection site; Arm was sore; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 15Mar2021 at 09:45 (at the age of 52-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Mar2021 at 12:00, 6 days after the vaccination, the patient experienced rash and soreness at the injection site. On an unknown date in Mar2021, the patient reported that initially arm was sore for two days, then the patient felt ok until day 6. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events rash and soreness at the injection site and sore arm were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508417
Sex: F
Age:
State: NJ

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Tiredness; muscle pain; chills; joint pain; Headache; Fever; injection site pain; Nausea; feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 03Apr2021 at 17:30 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. It was reported that the patient had no allergies to medications, food, or other products. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Concomitant medications included progesterone (MANUFACTURER UNKNOWN), dextromethorphan hydrobromide and guaifenesin (ROBITUSSIN DM) and azithromycin (MANUFACTURER UNKNOWN) started on an unknown date for an unknown indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Apr2021 at 6:00, the patient experienced tiredness, muscle pain, chills, joint pain, headache, fever, vaccination site pain, nausea and malaise. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tiredness, muscle pain, chills, joint pain, headache, fever, vaccination site pain, nausea and malaise were recovered on an unknown date in 2021. No follow-up attempts are needed; information about the lot number cannot be obtained.

Other Meds: PROGESTERONE; ROBITUSSIN DM; AZITHROMYCIN

Current Illness:

ID: 1508418
Sex: F
Age:
State:

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Left arm pit accompanied by pain and discomfort.; Left arm pit accompanied by pain and discomfort.; Severe swelling of the lymph node; Fever of 37.9; Severe pain in left arm; This is a spontaneous report received from a non-contactable consumer (patient). A 46-year-old non-pregnant female patient received BNT162B2 (COVID-19 VACCINE-MANUFACTURER UNKNOWN; Lot Number: ew0151), via an unspecified route of administration in the arm left on 01Apr2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 prior to vaccination on an unspecified date. The patient had history of known allergies to nickel. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and ibuprofen (ADVIL); all from an unknown dates taken for unknown indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced left arm pit accompanied by pain and discomfort on 02Apr2021, at 16:00 with outcome of recovering, severe swelling of the lymph node on 02Apr2021, at 16:00 with outcome of recovering, fever of 37.9 on 02Apr2021, at 16:00 with outcome of recovered on 04Apr2021, severe pain in left arm on 02Apr2021, at 16:00 with outcome of recovering. Details were as follows: on 02Apr2021 at 16:00, 24 hours following the injection, the patient experienced fever of 37.9 which lasted for almost two days. Severe pain in the left arm. Severe swelling of the lymph node in the left arm pit accompanied by pain and discomfort were noted. The lymph was visibly swollen 4 days after the injection. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of the left arm pit accompanied by pain and discomfort, severe swelling of the lymph node and severe pain in left arm was recovering; fever of 37.9 recovered on 04Apr2021. Pfizer is a marketing authorization holder of BNT162B2 in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of BNT162B2 has submitted the same report to the regulatory authorities. No follow-up attempts are possible. No further information is expected.

Other Meds: Vitamin d; MAGNESIUM; Advil

Current Illness:

ID: 1508419
Sex: M
Age:
State: FL

Vax Date: 04/02/2021
Onset Date: 04/04/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Loss of taste; Loss of smell; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 at 12:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient did not receive any other medications within two weeks prior to the vaccination. The patient had no allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 13:30, the patient experienced loss of taste and loss of smell 49.5 hours after taking the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events loss of taste and loss of smell was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1508420
Sex: F
Age:
State: CA

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: diarrhea; nausea; Arm would only move 30 degrees up; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150), via an unspecified route of administration in the left arm on 02Apr2021 (at the age of 22-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported and the patient had a history of allergy to peanuts. Concomitant medication included birth control (MANUFACTURER UNKNOWN) taken within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021, on day of shot the patient was able to move arm only 30 degrees up. On 03Apr2021 i.e., on Saturday night, the patient experienced diarrhea and nausea and again on Monday all day. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutics measures were not taken as a result of the events. The clinical outcome of the events diarrhea, nausea and arm would only move 30 degrees up were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508421
Sex: F
Age:
State: MD

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: severe stomach pain; spasms in stomach; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03Apr2021 at 12:45 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. Medical history included mTBI - post concussion syndrome. Concomitant medications included paracetamol (TYLENOL) for unspecified indication from one day before and day of (as reported). The patient previously took cefalexin (CEPHALEXIN) for unspecified indication on unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021, approximately 24 hours after the vaccine, the patient experienced very severe stomach pain and spasms in stomach and took 4 baths, switched positions constantly as it was hurting so bad. This lasted about 9 or 10 hours. The pain was very severe in the middle of stomach and was hurting to touch. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events severe stomach pain and spasms in stomach were recovered on 04Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021384951 same reporter/event/drug, different patient

Other Meds: TYLENOL

Current Illness:

ID: 1508422
Sex: F
Age:
State: MD

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Prolonged, pronounced joint pain.; On and off Pins and needles,; tingling in fingers arms legs and feet.; Sharp pains in legs and arms; Sharp pains in legs and arms; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8732) via an unspecified route of administration in the arm left on 25Mar2021 at 15:00 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 16:00, the patient experienced prolonged, pronounced joint pain, on and off pins and needles, tingling in fingers, arms, legs and feet and the patient also experienced sharp pains in legs and arms on the same day. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events prolonged, pronounced joint pain, on and off Pins and needles, tingling in fingers arms legs and feet and sharp pains in legs and arms were not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508423
Sex: M
Age:
State:

Vax Date:
Onset Date: 03/25/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Fever; Chills; Muscle aches; Strong headache; Photosensitivity; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ep7533) via an unspecified route of administration on an unknown date in 2021 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 25Mar2021, the patient experienced fever, chills, muscle aches, strong headache for duration of 24 hours and photosensitivity for the duration of 6 hours. The patient did not receive any treatment for the events. The clinical outcome of the events fever, chills and muscle aches were recovered on an unknown date in 2021 while the events strong headache and photosensitivity were recovered on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508424
Sex: M
Age:
State: CT

Vax Date: 04/02/2021
Onset Date: 04/03/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: pain in both feet; burning sensation in both feet; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er8730) via an unspecified route of administration in the arm left on 02Apr2021 at 09:45 as a single dose for COVID-19 immunisation. Medical history included shellfish allergy. Concomitant medications included hydrocortisone injection (CORTIZONE) in both feet for an unknown indication on 26Mar2021 and meloxicam (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6202) via an unspecified route of administration in the arm left on 12Mar2021 at 15:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 13:00 the patient experienced burning sensation and pain in both feet after having the COVID shot. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown if patient received any treatment for the events. The patient was asking could this be reacting with the cortisone injection received on 26Mar2021. The clinical outcome of the events pain and burning sensation in both feet was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: CORTIZONE; MELOXICAM

Current Illness:

ID: 1508425
Sex: F
Age:
State: MN

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Chills; fatigue; decay; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 38-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 07Apr2021 20:00 (at the age of 38 years old) (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient has no known allergies to medications, food, or other products. No other vaccine was administered in four weeks and no other medication within two weeks prior to vaccination. On 07Apr2021 21:00, the patient experienced chills, fatigue, decay. No treatment was received for the adverse events. The patient has not been diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 post vaccination. The outcome of the events was recovering. Information about lot/batch number has been requested. Follow-up (07Jul2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1508426
Sex: F
Age:
State:

Vax Date: 04/05/2021
Onset Date: 04/06/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Fever of 100.4; Chills; Aching joints; Stomach upset; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 13:15 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to penicillin and sulfa drugs from an unknown date. Concomitant medications included paracetamol (TYLENOL) taken for unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 13Mar2021 at 14:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021, the patient experienced fever of 100.4, chills, aching joints and stomach upset. The patient's body temperature was found to be 100.4 (unit unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events fever, chills, aching joints and stomach upset was not recovered at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds: TYLENOL

Current Illness:

ID: 1508427
Sex: F
Age:
State: NY

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Slight itchy feeling underneath skin; Red unraised 2.5 inch circle around theinjection site- red rash like; Small raised bump size of nail bed; Arm felt slightly sore; Felt dizzy and lightheaded; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EN6207) via an unspecified route of administration in the right arm on 19Mar2021 at 16:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Concomitant medications included phentermine (MANUFACTURER UNKNOWN) from an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On (19Mar2021), Day 1 of initial injection, arm did not hurt. Day 2 (20Mar2021) experienced small raised bump size of nail bed (arm swelling) and arm felt slightly sore (pain in arm). On day 12 (30Mar2021), unknowingly found red unraised 2.5-inch circle around the injection site, red rash like (vaccination site erythema) slight itchy feeling underneath skin (pruritus). The patient felt dizzy and lightheaded for those 12 days as well. The patient called the 800 and asked if she should report it. She was informed that those were slight side effects that usually went away within 5 days after the shot. She asked if she should report considering it was well after that timeframe and she was informed that she could if she wanted to. She also had picture if needed. She was assuming that she had a slight allergic reaction but was wondering if anyone else had the same thing happened for that length of time. She decided to wait until the day before going to doctor. By then it had disappeared so she did not report it anywhere else. The patient was scheduled for her second dose on 09Apr2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of light headed, arm swelling, pain in arm, vaccination site erythema and pruritus were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: PHENTERMINE

Current Illness:

ID: 1508428
Sex: F
Age:
State:

Vax Date: 04/09/2021
Onset Date:
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: asthma; fever; chills; flu; coughing; body aches; could not breathe; This is a spontaneous report from a contactable consumer or other non hcp. A 27-year-old female patient received bnt162b2 (BNT162B2, solution for injection), dose 1 via an unspecified route of administration on 09Apr2021 as dose 1, single for COVID-19 immunisation. Medical history included ongoing asthma. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced asthma, fever, chills, coughing, body aches, could not breathe. She and her daughter got the first Pfizer covid vaccine on 09Apr. Nothing happened to her but her daughter, who is special needs and has asthma, has a fever, chills and it feels like she has the flu. She is coughing, has body aches and her lungs closed up and she could not breathe. Her doctors gave her prednisone, albuterol and budesonide as well as promethazine with codeine for her cough. She has a fever up and down. It's been going on for 72 hour now.Therapeutic measures were taken as a result of coughing. The outcome of all the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness: Asthma

ID: 1508429
Sex: F
Age:
State: TX

Vax Date: 04/09/2021
Onset Date: 04/01/2021
Rec V Date: 07/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: chest pain on her left side; itching; chills; shortness of breath; Nauseated; she is breaking down with a sweat; I don't feel good, I don't feel right; tired; This is a spontaneous report from a contactable consumer. A (62-year old (age at vaccination) female patient with height 165 cm and weight; 77.56 kg received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number; EN6207) dose 2 via an unspecified route of administration on 09Apr2021 in left arm as DOSE 2, SINGLE for covid-19 immunization. Medical history included cardiac disorder, diabetes mellitus, blood cholesterol increased and was mentioned that she takes medication for all, Blood pressure high, gastritis, congestive heart failure, arthritis (dates unspecified). Historical vaccine included first dose of BNT162B2 via an unspecified route of administration on 19Mar2021 as single dose in left arm for covid-19 immunisation. Concomitant medications were not reported. On 09Apr2021, the patient experienced itching the same day as the vaccine and she took a teaspoon of benadryl. On the Saturday, experienced chills, shortness of breath, tired, chest pain on her left side, she is breaking down with a sweat. Consumer stated, "I'm calling to tell you about Pfizer, I had took last one, Friday 09Apr2021 that was on Friday. so next day on Saturday I started getting side effects. I started itching, short of breath, chills. I was getting short of breath, itching and don't know what else is going on. I feel kind. This morning I had a little chest pain." Consumer further stated ?' Nauseated. Last Friday. I had the 2nd one. On 09Apr2021.". Consumer stated, "Right now I don't feel good. I don't feel right." Consumer stated, " this is serious, they had it on the news this stuff giving people side effects." I had the 1st on 19Mar2021. Apr I had the last one, 09Apr2021.". Probed for 2nd shot COVID vaccine LOT number, consumer stated, "EN6207, yes." Probed for expiration date: consumer stated, "I don't see expiration date." Anatomical site of administration: consumer stated, "Both on the left arm. Left arm." Probed for medical condition, consumer stated, " I take medicine only for asthma (Further clarification unknown), The 81 the low dose." Consumer stated, "I have arthritis too. In my right knee, I use cream on my knee. My doctor prescribe some cream (Further clarification unknown) for me to use for the knee, for the pain. In July2021 I have knee replacement too." Consumer stated, "I took Benadryl when I start itching.'' Therapeutic measures were taken as a result of itching (pruritus). Investigation assessment; no. The outcome of event pruritus, Chills was recovered on an unspecified date, dyspnoea was not recovered, fatigue, chest pain, hyperhidrosis, feeling abnormal and nausea was unknown. No follow-up attempts are needed. Information about lot/batch number cannot be obtained. Follow-up (13Apr2021): New infromation recieved from a contactable consumer. This 62-year-old consumer reported for herself that which included: Patient details (age and age at vaccination, height, weight, medical history) added, suspect drug details (lot number, anatomical location) added, event details (new events feeling abnormal, nauseated) added outcome of event 'shortness of breath' was updated as 'Not recovered/Not resolved' and clinical information added. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm